相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Copper metabolism as a unique vulnerability in cancer
Vinit C. Shanbhag et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2021)
Therapeutic potential of a copper complex loaded in pH-sensitive long circulating liposomes for colon cancer management
Jacinta O. Pinho et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Antimicrobial Nano-Agents: The Copper Age
Maria Laura Ermini et al.
ACS NANO (2021)
The great escape: tumour cell plasticity in resistance to targeted therapy
Soufiane Boumahdi et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Is Hydrogen Sulfide a Concern During Treatment of Lung Adenocarcinoma With Ammonium Tetrathiomolybdate?
Xiang Li et al.
FRONTIERS IN ONCOLOGY (2020)
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
Charles Pottier et al.
CANCERS (2020)
Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas
Chan Chung et al.
CANCER CELL (2020)
Copper homeostasis: Emerging target for cancer treatment
Yueqin Li
IUBMB LIFE (2020)
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion
Florida Voli et al.
CANCER RESEARCH (2020)
The molecular mechanisms of copper metabolism and its roles in human diseases
Ji Chen et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2020)
The histone H3-H4 tetramer isa copper reductase enzyme
Narsis Attar et al.
SCIENCE (2020)
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer
Leo Aubert et al.
NATURE COMMUNICATIONS (2020)
Biomedical applications of copper ionophores
Valentina Oliveri
COORDINATION CHEMISTRY REVIEWS (2020)
Transition metal chelators, pro-chelators, and ionophores as small molecule cancer chemotherapeutic agents
Axel Steinbrueck et al.
CHEMICAL SOCIETY REVIEWS (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer
Ping Zhou et al.
BIOMATERIALS (2019)
Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death
Ze Yu et al.
CELL PROLIFERATION (2019)
Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature
Gaurav V. Sarode et al.
METABOLOMICS (2019)
Inhibition of Copper Transport Induces Apoptosis in Triple-Negative Breast Cancer Cells and Suppresses Tumor Angiogenesis
Olga Karginova et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Effects of Copper Chelation on BRAFV600E Positive Colon Carcinoma Cells
Silvia Baldari et al.
CANCERS (2019)
A Dose Escalation Study of Trientine Plus Carboplatin and Pegylated Liposomal Doxorubicin in Women With a First Relapse of Epithelial Ovarian, Tubal, and Peritoneal Cancer Within 12 Months After Platinum-Based Chemotherapy
Yu-Fang Huang et al.
FRONTIERS IN ONCOLOGY (2019)
Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas
Robert F. Koncar et al.
CANCER RESEARCH (2019)
Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression
Jon D. Larson et al.
CANCER CELL (2019)
Chelating principles in Menkes and Wilson diseases Choosing the right compounds in the right combinations at the right time
Nina Horn et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2019)
Epigenetic modifications of histones in cancer
Zibo Zhao et al.
GENOME BIOLOGY (2019)
The DNA methyltransferase family: a versatile toolkit for epigenetic regulation
Frank Lyko
NATURE REVIEWS GENETICS (2018)
Link of impaired metal ion homeostasis to mitochondrial dysfunction in neurons
Eunju Nam et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2018)
Receptor Tyrosine Kinase-Targeted Cancer Therapy
Toshimitsu Yamaoka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid Cancer
MengMeng Xu et al.
CLINICAL CANCER RESEARCH (2018)
A Copper(II) Phenanthroline Metallopeptide That Targets and Disrupts Mitochondrial Function in Breast Cancer Stem Cells
Kristine Laws et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Glutamate and α-ketoglutarate: key players in glioma metabolism
Andreas Maus et al.
AMINO ACIDS (2017)
Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases
Nancy Chan et al.
CLINICAL CANCER RESEARCH (2017)
D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H2O2-mediated oxidative stress
Sebastian J. Sciegienka et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Copper transporter 1 in human colorectal cancer cell lines: Effects of endogenous and modified expression on oxaliplatin cytotoxicity
Haigang Cui et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2017)
Epigenetic regulation of RTK signaling
Jennifer M. Spangle et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG
Francisco J. Cordero et al.
MOLECULAR CANCER RESEARCH (2017)
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
Andrea Piunti et al.
NATURE MEDICINE (2017)
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches
C. C. Wong et al.
ONCOGENE (2017)
Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells
Eugene M. H. Yee et al.
SCIENTIFIC REPORTS (2017)
Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors
Donita C. Brady et al.
CANCER RESEARCH (2017)
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
Nathan J. Lanning et al.
CANCER & METABOLISM (2017)
A Cu(II) complex targeting the translocator protein: in vitro and in vivo antitumor potential and mechanistic insights
D. Montagner et al.
CHEMICAL COMMUNICATIONS (2017)
Triethylenetetramine modulates polyamine and energy metabolism and inhibits cancer cell proliferation
Mervi T. Hyvonen et al.
BIOCHEMICAL JOURNAL (2016)
HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma
Yanxin Pei et al.
CANCER CELL (2016)
Wilson Disease: Epigenetic effects of choline supplementation on phenotype and clinical course in a mouse model
Valentina Medici et al.
EPIGENETICS (2016)
Copper chelation by trientine dihydrochloride inhibits liver RFA-induced inflammatory responses in vivo
Ji-ming Yin et al.
INFLAMMATION RESEARCH (2016)
Coupling between Histone Conformations and DNA Geometry in Nucleosomes on a Microsecond Timescale: Atomistic Insights into Nucleosome Functions
Alexey K. Shaytan et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin
Cristine L. Chisholm et al.
ONCOTARGET (2016)
The Variations of Glycolysis and TCA Cycle Intermediate Levels Grown in Iron and Copper Mediums of Trichoderma harzianum
Zehra Tavsan et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2015)
Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo
Szu-Jung Chen et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Nucleosome adaptability conferred by sequence and structural variations in histone H2A-H2B dimers
Alexey K. Shaytan et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2015)
Epigenetic Changes of EGFR Have an Important Role in BRAF Inhibitor-Resistant Cutaneous Melanomas
Jinhua Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers
Kyu Kwang Kim et al.
SCIENTIFIC REPORTS (2015)
Trientine induced colitis during therapy for Wilson disease: a case report and review of the literature
Salih Boga et al.
BMC PHARMACOLOGY & TOXICOLOGY (2015)
Pathology, molecular genetics, and epigenetics of diffuse intrinsic pontine glioma
Pawel Buczkowicz et al.
FRONTIERS IN ONCOLOGY (2015)
An overview of targeted cancer therapy
Viswanadha Vijaya Padma
BIOMEDICINE-TAIWAN (2015)
Krebs cycle intermediates regulate DNA and histone methylation: Epigenetic impact on the aging process
Antero Salminen et al.
AGEING RESEARCH REVIEWS (2014)
Pathological mitochondrial copper overload in livers of Wilson's disease patients and related animal models
Hans Zischka et al.
HUMAN DISORDERS OF COPPER METABOLISM II (2014)
Low Expression of the FoxO4 Gene may Contribute to the Phenomenon of EMT in Non-small Cell Lung Cancer
Ming-Ming Xu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
The transcription factor FOXO4 is down-regulated and inhibits tumor proliferation and metastasis in gastric cancer
Linna Su et al.
BMC CANCER (2014)
mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms
Kathleen A. Wilson-Edell et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Akt-Dependent Metabolic Reprogramming Regulates Tumor Cell Histone Acetylation
Joyce V. Lee et al.
CELL METABOLISM (2014)
Maternal choline modifies fetal liver copper, gene expression, DNA methylation, and neonatal growth in the tx-j mouse model of Wilson disease
Valentina Medici et al.
EPIGENETICS (2014)
Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies
Siqing Fu et al.
INVESTIGATIONAL NEW DRUGS (2014)
A study of oxidative stress, cytokines and glutamate in Wilson disease and their asymptomatic siblings
Jayantee Kalita et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
The promise of copper lowering therapy with tetrathiomolybdate in the cure of cancer and in the treatment of inflammatory disease
George J. Brewer
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2014)
Copper is required for oncogenic BRAF signalling and tumorigenesis
Donita C. Brady et al.
NATURE (2014)
Transition metal complexes with bioactive ligands: mechanisms for selective ligand release and applications for drug delivery
Anna K. Renfrew
METALLOMICS (2014)
Controlled Administration of Penicillamine Reduces Radiation Exposure in Critical Organs during 64Cu-ATSM Internal Radiotherapy: A Novel Strategy for Liver Protection
Yukie Yoshii et al.
PLOS ONE (2014)
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse
S. Jain et al.
ANNALS OF ONCOLOGY (2013)
Influence of Metabolism on Epigenetics and Disease
William G. Kaelin et al.
CELL (2013)
Complex formation equilibria of CuII and ZnII with triethylenetetramine and its mono- and di-acetyl metabolites
Valeria M. Nurchi et al.
DALTON TRANSACTIONS (2013)
Wilson's Disease: Changes in Methionine Metabolism and Inflammation Affect Global DNA Methylation in Early Liver Disease
Valentina Medici et al.
HEPATOLOGY (2013)
Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer
Bryan J. Schneider et al.
INVESTIGATIONAL NEW DRUGS (2013)
Rapid Copper Acquisition by Developing Murine Mesothelioma: Decreasing Bioavailable Copper Slows Tumor Growth, Normalizes Vessels and Promotes T Cell Infiltration
Andrew Crowe et al.
PLOS ONE (2013)
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Peter W. Lewis et al.
SCIENCE (2013)
Biological activity of synthetic ionophores: ion transporters as prospective drugs?
Ignacio Alfonso et al.
CHEMICAL SCIENCE (2013)
Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis
Jonathon Telianidis et al.
FRONTIERS IN AGING NEUROSCIENCE (2013)
Copper influx transporter 1 is required for FGF, PDGF and EGF-induced MAPK signaling
Cheng-Yu Tsai et al.
BIOCHEMICAL PHARMACOLOGY (2012)
A randomised controlled trial of a theory-based intervention to improve sun protective behaviour in adolescents ('you can still be HOT in the shade'): study protocol
Anna L. Hawkes et al.
BMC CANCER (2012)
Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells
Gipsy Majumdar et al.
BMC GENOMICS (2012)
Potent and selective inhibition of T-cell protein tyrosine phosphatase (TCPTP) by a dinuclear copper(II) complex
Caixia Yuan et al.
CHEMICAL COMMUNICATIONS (2012)
Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
Ji Young Yoo et al.
CLINICAL CANCER RESEARCH (2012)
S-Adenosylmethionine Inhibits the Growth of Cancer Cells by Reversing the Hypomethylation Status of c-myc and H-ras in Human Gastric Cancer and Colon Cancer
Jin Luo et al.
International Journal of Biological Sciences (2012)
A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling
Michelle L. Turski et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent
Siqing Fu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Advance in the pathogenesis and treatment of Wilson disease
Qin-Yun Dong et al.
TRANSLATIONAL NEURODEGENERATION (2012)
Copper: An essential metal in biology
Richard A. Festa et al.
CURRENT BIOLOGY (2011)
Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines
Kyu Kwang Kim et al.
GYNECOLOGIC ONCOLOGY (2011)
Mammalian Sirtuins and Energy Metabolism
Xiaoling Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease
Hans Zischka et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Genotoxicity of the copper antineoplastic coordination complexes casiopeinas®
J. Serment-Guerrero et al.
TOXICOLOGY IN VITRO (2011)
Cytochrome c oxidase deficiency: Patients and animal models
Francisca Diaz
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
Seiko Ishida et al.
CANCER CELL (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry
F. Wang et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Phosphatidylinositol 3-Kinase (PI3K) Signaling via Glycogen Synthase Kinase-3 (Gsk-3) Regulates DNA Methylation of Imprinted Loci
Anthony P. Popkie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor α and Poly (ADP-ribose) Polymerase As Potential Therapeutic Targets
Maryam Zarghooni et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis
Pawan Kumar et al.
MOLECULAR CANCER (2010)
Triethylenetetramine Pharmacology and Its Clinical Applications
Jun Lu
MOLECULAR CANCER THERAPEUTICS (2010)
Recognition, Diagnosis, and Management of Wilson's Disease
George J. Brewer
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
Constrained (L-)-S-adenosyl-L-homocysteine (SAH) analogues as DNA methyltransferase inhibitors
Ljubomir Isakovic et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer
Dawn P. G. Brown et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Anshul Gupte et al.
CANCER TREATMENT REVIEWS (2009)
Antiangiogenic Tetrathiomolybdate Protects against Her2/neu-Induced Breast Carcinoma by Hypoplastic Remodeling of the Mammary Gland
Quintin Pan et al.
CLINICAL CANCER RESEARCH (2009)
Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology
Lee M. Ellis et al.
CLINICAL CANCER RESEARCH (2009)
Metal Ionophores - An Emerging Class of Anticancer Drugs
Wei-Qun Ding et al.
IUBMB LIFE (2009)
Sustained Activation of Glial Cell Epidermal Growth Factor Receptor by Bis(thiosemicarbazonato) Metal Complexes Is Associated with Inhibition of Protein Tyrosine Phosphatase Activity
Katherine Ann Price et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Linking DNA methylation and histone modification: patterns and paradigms
Howard Cedar et al.
NATURE REVIEWS GENETICS (2009)
ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
Kathryn E. Wellen et al.
SCIENCE (2009)
A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: Final results
Harvey I. Pass et al.
ANNALS OF THORACIC SURGERY (2008)
Dietary manipulation on in musculoskeletal conditions
Margaret P. Rayman et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2008)
Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis
Willianne I. M. Vonk et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Diagnosis and treatment of Wilson disease: An update
Eve A. Roberts et al.
HEPATOLOGY (2008)
Mechanisms for copper acquisition, distribution and regulation
Byung-Eun Kim et al.
NATURE CHEMICAL BIOLOGY (2008)
Determination of triethylenetetramine (TETA) and its metabolites in human plasma and urine by liquid chromatography-mass spectrometry (LC-MS)
Jun Lu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells
Anshul Gupte et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Copper ions inhibit S-adenosylhomocysteine hydrolase by causing dissociation of NAD+ cofactor
Mengyao Li et al.
BIOCHEMISTRY (2007)
Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions:: Mechanisms and consequences
Andreas Barthel et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation
Anshul Gupte et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2007)
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study
U. Merle et al.
GUT (2007)
Functions of Site-Specific Histone Acetylation and Deacetylation
Mona D. Shahbazian et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2007)
Histone acetyltransferase complexes: one size doesn't fit all
Kenneth K. Lee et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions
Philippe L. Walter et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2006)
Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function
Yasuhiro Nose et al.
CELL METABOLISM (2006)
Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer
N. Lynn Henry et al.
ONCOLOGY (2006)
Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays
M Nishigaki et al.
CANCER RESEARCH (2005)
Oxidative stress is involved in inhibition of copper on histone acetylation in cells
CJ Lin et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2005)
Role of p53 and reactive oxygen species in apoptotic response to copper and zinc in epithelial breast cancer cells
EA Ostrakhovitch et al.
APOPTOSIS (2005)
The SET-domain protein superfamily: protein lysine methyltransferases
SC Dillon et al.
GENOME BIOLOGY (2005)
Copper induces histone hypoacetylation through directly inhibiting histone acetyltransferase activity
JH Kang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2004)
Heme, iron, and the mitochondrial decay of ageing
H Atamna
AGEING RESEARCH REVIEWS (2004)
Respiratory metabolism: glycolysis, the TCA cycle and mitochondrial electron transport
AR Fernie et al.
CURRENT OPINION IN PLANT BIOLOGY (2004)
Cu2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo
CT Sheline et al.
ANNALS OF NEUROLOGY (2004)
Inhibition of the growth of squamous cell carcinoma by tetrathiomolybdate-induced copper suppression in a murine model
C Cox et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2003)
Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1
MJ Petris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition
M Moriguchi et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo
CT Sheline et al.
ANNALS OF NEUROLOGY (2002)
Copper ions strongly activate the phosphoinositide-3-kinase/Akt pathway independent of the generation of reactive oxygen species
EA Ostrakhovitch et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells
J Yoshi et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Copper transport and metabolism are normal in aceruloplasminemic mice
LA Meyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The copper transporter CTR1 provides an essential function in mammalian embryonic development
YM Kuo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma
C Cox et al.
LARYNGOSCOPE (2001)
Paradoxical effects of copper and manganese on brain mitochondrial function
P Heron et al.
LIFE SCIENCES (2001)
Mechanism of Cu,Zn-superoxide dismutase activation by the human metallochaperone hCCS
TD Rae et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Oxidative-phosphorylation defects in liver of patients with Wilson's disease
M Gu et al.
LANCET (2000)
Cardiovascular disease from copper deficiency - A history
LM Klevay
JOURNAL OF NUTRITION (2000)
分享论文
